Forms Processing
PRODUCTS
-
Natoli Scientific’s preclinical stability studies represent a critical facet of our pharmaceutical testing services, providing essential data on the shelf life and storage conditions of drug candidates. These studies are expertly designed to evaluate physical, chemical, and microbiological stability, ensuring that formulations retain their safety, efficacy, and quality over time. Our state-of-the-art facilities simulate various environmental conditions to scrutinize the integrity of products under stress-testing scenarios. The results gleaned from our stability studies guide the development of robust drug formulations and packaging, aid in regulatory submissions, and lay the groundwork for successful commercialization.
-
Capture EHR/EMR data in TrialKit with no integration required.
-
It’s about time.
Modern eConsent.
Solved.Deliver complex eConsent experiences that participants will love. Drive compliance and retention with truly informed participants, using a system that is easy to configure and manage from site to subject.
-
For your efficient and error-proof production: Our world-leading Manufacturing Execution System (MES) Suite PAS-X controls, monitors, and documents your processes digitally and in real time throughout the entire manufacturing cycle.
-
ClinicReady is the surrogate for outsourced drug development team for preclinical biotechs.
WHITE PAPERS AND CASE STUDIES
-
Inside A Collaboration To Design Cutting Edge Modular Cleanrooms
Learn about a collaboration that has yielded advanced modular cleanrooms, integrating cutting-edge building automation, critical monitoring, and data aggregation for manufacturing intelligence.
-
Ultra-Wideband: At Home On The Range
Explore how a technology leader developed a UWB-based solution to track cattle on dairy farms. This innovative system enhances animal welfare, productivity, and overall farm efficiency.
-
How Close Are We To The Clinic?
Organoids are offering new possibilities in therapeutic screening, regenerative medicine, and even organ transplantations. However, there are still several challenges to overcome.
-
OPTICHECK Technology Built-In – Diagnostics, Verification, And Functional Safety With OPTIMASS Coriolis Mass Flow Meters
State-of-the-art measuring devices such as OPTIMASS Coriolis mass flow meters combine robust measuring principles and powerful electronics to produce a wide range of readings and device-specific data. OPTICHECK technology built-in leverages the features of the devices to translate their available comprehensive measuring system data into sophisticated diagnostics information for plant personnel.
-
How Waterloo Harnessed Qatium's Digital Platform
Read about the City of Waterloo, that needed an intuitive, low-cost tool to empower operators without requiring specialized technical expertise.
-
Boosting CMC Regulatory Efficiency In Gene Therapy
Ensure your business stays ahead in today’s complex regulatory environment by implementing robust regulatory affairs strategies that streamline compliance and product approvals.
-
Digital Endpoint Resource Guide: Obesity And Related Metabolic Disorders
Explore how digital health technologies can enhance obesity treatment by providing critical insights beyond weight loss.
-
Is Sustainability The Key To Agile Biopharma Manufacturing?
In biologics manufacturing, change is constant. Discover how new innovations and a focus on sustainability have gotten 62% of executives to prioritize eco-friendly practices, which reflects a commitment to long-term viability.
-
Emory University Uses Oracle Cloud To Help Fight Parkinson's Disease
Discover how researchers at Emory University were able to overcome challenges with computational resources and enable faster compute speeds and HIPAA compliance.
-
MilliporeSigma's 97-Day Implementation Success Story
Read how MilliporeSigma transformed validation processes with a digital validation system to achieve compliance in just 97 days, as well as learn key takeaways from their swift transition.
-
FDA Recommendations For Gene Therapy For PMDs
Explore insight into the strategies and FDA recommendations for executing gene therapy development programs, specifically for primary mitochondrial diseases (PMDs).
-
Comparing Patient And Practice Characteristics
Explore research that suggests investments to expand the clinical research footprint among practices with low research engagement could help address persistent inequities in cancer clinical trial representation.
NEWS
-
Salesforce Brings Agentic AI To The Field Service Sector To Tackle Scheduling, Reporting, And On-The-Job Troubleshooting4/11/2025
Surging demand is pushing field service teams to the limit. Inefficient scheduling is the #1 time drain on field service teams, and skilled tradespeople and technicians waste nearly an entire workday a week on administrative work — time that should go toward hands-on repairs and customer service.
-
Insurance Pros Of Central Arkansas Selects EZLynx To Modernize Operations And Enhance Client Service3/11/2025
EZLynx, an Applied company, today announced that Insurance Pros of Central Arkansas has selected the EZLynx management system to enhance its operations and give agents back valuable time to focus on client interactions.
-
ServiceNow Unveils Autonomous Procurement At DPW Amsterdam10/8/2025
Building on the AI agents ServiceNow launched at Knowledge 2025, I’m thrilled to share what’s next: new AI agents and fresh capabilities—all aimed at ushering in autonomous procurement.
-
VisionWave Announces Issuance Of New U.S. Patent, Expanding Enforceable Protection Across Its Core RF Imaging And AI Platform12/23/2025
VisionWave Technologies, Inc., a subsidiary of VisionWave Holdings, Inc. (NASDAQ: VWAV) (“VisionWave”), today announced that the United States Patent and Trademark Office (“USPTO”) has issued a new U.S. patent covering systems and methods for real-time movement, position detection, and imaging.
-
CEA-Leti Reports Co-Integration Of GaN MicroLED And Organic Photodetectors For Multifunctional Display Applications5/15/2025
Targeting next-generation of display technology, CEA-Leti today presented its heterogeneous co-integration of GaN microLED technology and organic photodetectors (OPDs), a major step toward multifunctional displays that combine both display and sensing capabilities.